For many people living with atherosclerotic cardiovascular disease, managing risk is a lifelong journey. One major concern is how different physical factors, such as body mass index (BMI), affect the effectiveness of life-saving medications. New data from a large study involving over 27,000 patients provides clearer insight into how the medication evolocumab performs across different weight categories.
The researchers conducted a randomized controlled trial to see how many people experienced major heart events—such as heart attacks, strokes, or hospitalizations for unstable angina. They compared those taking the drug evolocumab against those taking a placebo over a period of about two years. The study specifically looked at whether the medication worked differently for patients with lower versus higher body mass indices.
The results showed that while evolocumab reduced the risk of major heart events for everyone in the study, the benefit was much more pronounced for people with a higher BMI. For patients with a BMI of 35 or more, there was a 29% relative reduction in the risk of serious heart problems compared to those taking a placebo. In contrast, patients with a lower BMI (under 30) saw an 11% reduction. While the percentage of protection was higher for those with a higher BMI, it is important to look at the absolute numbers as well: the actual risk reduction was 5.7% for the higher weight group and 1.4% for the lower weight group.
It is important to keep these findings in perspective. While the data shows a clear trend that the medication is highly effective for those with a higher BMI, the absolute risk reductions across all groups remain relatively small. This means that while the drug provides significant protection, it is one piece of a larger management plan. Additionally, this study was conducted over about two years; long-term effects beyond that window are not fully detailed here.
For patients today, these findings mean that if you have a higher BMI and heart disease, evolocumab may offer particularly strong protection against major cardiac events. However, because every patient's health profile is unique, you should not make changes to your medication based on this study alone. Talk to your doctor about how your specific weight and medical history influence the best treatment plan for your heart health.